/PRNewswire/ For many companies, entering the global market is a daunting challenge. These obstacles can come in various forms. Sometimes the problem is.
In this article, Dr. Pingju Ge discusses the parallels between viruses, vaccines, and more. She also touches on vaccine manufacturing and the processes behind this.
In this article, Dr Carrie Qin discusses how she has devised methods to overcome challenges in transmembrane protein manufacturing and also how this can accelerate the development of immunotherapeutics.
"Welcome to ViruStop!" Recently, ACROBiosystems officially announced the launch of a new brand, ViruStop. ViruStop is specifically designed for virus research and development, committing to accelerating the process of infectious diseases vaccine research, development and approval.